{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Limb+Girdle+Muscular+Dystrophy&page=2", "query": { "condition": "Limb Girdle Muscular Dystrophy", "page": 2 }, "page_size": 10 }, "pagination": { "page": 2, "page_size": 10, "total_count": 10, "total_pages": 1, "next_page_url": null, "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Limb+Girdle+Muscular+Dystrophy&page=1&page_size=10" }, "source": "remote", "last_synced_at": "2026-06-11T09:28:29.492Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT00390104", "title": "Molecular Analysis of Patients With Neuromuscular Disease", "overall_status": "RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Neuromuscular; Disorder, Hereditary", "Duchenne/Becker Muscular Dystrophy", "Limb-girdle Muscular Dystrophy" ], "interventions": [], "intervention_types": [], "sponsor": "Boston Children's Hospital", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "1 Week", "maximum_age": "100 Years", "sex": "ALL", "summary": "1 Week to 100 Years" }, "enrollment_count": 1000, "start_date": "2002-01", "completion_date": "2027-12-31", "has_results": false, "last_update_posted_date": "2023-04-24", "last_synced_at": "2026-06-11T09:28:29.492Z", "location_count": 1, "location_summary": "Boston, Massachusetts", "locations": [ { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT00390104" }, { "nct_id": "NCT03439514", "title": "A Study of ARRY-371797 (PF-07265803) in Patients With Symptomatic Dilated Cardiomyopathy Due to a Lamin A/C Gene Mutation", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Dilated Cardiomyopathy", "Lamin A/C Gene Mutation" ], "interventions": [ { "name": "ARRY-371797 (PF-07265803)", "type": "DRUG" }, { "name": "Placebo", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 77, "start_date": "2018-04-17", "completion_date": "2022-10-13", "has_results": true, "last_update_posted_date": "2024-01-09", "last_synced_at": "2026-06-11T09:28:29.492Z", "location_count": 56, "location_summary": "Birmingham, Alabama • Mobile, Alabama • Chandler, Arizona + 26 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Mobile", "state": "Alabama" } ], "official_url": "https://clinicaltrials.gov/study/NCT03439514" }, { "nct_id": "NCT05286281", "title": "A Study To Evaluate The Pharmacokinetics, Excretion, Mass Balance and Metabolism of PF-07265803", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Healthy" ], "interventions": [ { "name": "PF-07265803", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "MALE", "summary": "18 Years and older · Male only" }, "enrollment_count": 6, "start_date": "2022-03-31", "completion_date": "2022-05-26", "has_results": true, "last_update_posted_date": "2024-03-29", "last_synced_at": "2026-06-11T09:28:29.492Z", "location_count": 1, "location_summary": "Madison, Wisconsin", "locations": [ { "city": "Madison", "state": "Wisconsin" } ], "official_url": "https://clinicaltrials.gov/study/NCT05286281" }, { "nct_id": "NCT00893334", "title": "Evaluation of Limb-Girdle Muscular Dystrophy", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Becker Muscular Dystrophy", "Limb-Girdle Muscular Dystrophy, Type 2A (Calpain-3 Deficiency)", "Limb-Girdle Muscular Dystrophy, Type 2B (Miyoshi Myopathy, Dysferlin Deficiency)", "Limb-Girdle Muscular Dystrophy, Type 2I (FKRP-deficiency)" ], "interventions": [], "intervention_types": [], "sponsor": "Cooperative International Neuromuscular Research Group", "sponsor_class": "NETWORK", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 60, "start_date": "2009-04", "completion_date": "2013-12", "has_results": false, "last_update_posted_date": "2014-03-07", "last_synced_at": "2026-06-11T09:28:29.492Z", "location_count": 2, "location_summary": "Washington D.C., District of Columbia • Charlotte, North Carolina", "locations": [ { "city": "Washington D.C.", "state": "District of Columbia" }, { "city": "Charlotte", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT00893334" }, { "nct_id": "NCT06952686", "title": "A Study of SRP-9005 in Limb Girdle Muscular Dystrophy Type 2C/R5 Pediatric and Adult Participants", "overall_status": "WITHDRAWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Muscular Dystrophies, Limb-Girdle" ], "interventions": [ { "name": "SRP-9005", "type": "BIOLOGICAL" }, { "name": "Corticosteroid", "type": "DRUG" } ], "intervention_types": [ "BIOLOGICAL", "DRUG" ], "sponsor": "Sarepta Therapeutics, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "4 Years", "maximum_age": null, "sex": "ALL", "summary": "4 Years and older" }, "enrollment_count": 0, "start_date": "2025-06-30", "completion_date": "2032-03-30", "has_results": false, "last_update_posted_date": "2025-08-06", "last_synced_at": "2026-06-11T09:28:29.492Z", "location_count": 1, "location_summary": "Norfolk, Virginia", "locations": [ { "city": "Norfolk", "state": "Virginia" } ], "official_url": "https://clinicaltrials.gov/study/NCT06952686" }, { "nct_id": "NCT03492346", "title": "Limb Girdle Muscular Dystrophy Type 2E Recruitment Study", "overall_status": "UNKNOWN", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Limb-Girdle Muscular Dystrophy, Type 2E" ], "interventions": [], "intervention_types": [], "sponsor": "Nationwide Children's Hospital", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "3 Years", "maximum_age": "15 Years", "sex": "ALL", "summary": "3 Years to 15 Years" }, "enrollment_count": 25, "start_date": "2018-03-28", "completion_date": "2023-03-28", "has_results": false, "last_update_posted_date": "2023-03-06", "last_synced_at": "2026-06-11T09:28:29.492Z", "location_count": 1, "location_summary": "Columbus, Ohio", "locations": [ { "city": "Columbus", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT03492346" }, { "nct_id": "NCT01783509", "title": "Limb Girdle Muscular Dystrophy (LGMD) Natural History", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Muscular Dystrophies, Limb-Girdle (GENETICALLY CONFIRMED)" ], "interventions": [], "intervention_types": [], "sponsor": "Wake Forest University Health Sciences", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "6 Years", "maximum_age": null, "sex": "ALL", "summary": "6 Years and older" }, "enrollment_count": 13, "start_date": "2011-11", "completion_date": "2017-07", "has_results": false, "last_update_posted_date": "2022-04-28", "last_synced_at": "2026-06-11T09:28:29.492Z", "location_count": 1, "location_summary": "Charlotte, North Carolina", "locations": [ { "city": "Charlotte", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT01783509" }, { "nct_id": "NCT05902351", "title": "Natural History Study for Charcot Marie Tooth Disease", "overall_status": "RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Charcot-Marie-Tooth Disease", "Charcot-Marie-Tooth", "Charcot-Marie-Tooth Disease, Type IA", "Charcot-Marie-Tooth Disease Type 2A", "Charcot-Marie-Tooth Disease Type 2", "Charcot-Marie-Tooth Disease, Type 2C", "Charcot-Marie-Tooth Disease Type 2A2B", "Charcot-Marie-Tooth Disease Type 2B2", "Charcot-Marie-Tooth Disease Type 2A1", "Charcot-Marie-Tooth Disease Type 4B1", "Charcot-Marie-Tooth Disease, Type IB", "Charcot-Marie-Tooth Disease Type 2B1", "Charcot-Marie-Tooth Disease Type 2U (Diagnosis)", "Charcot-Marie-Tooth Disease Type 4A", "Charcot-Marie-Tooth Disease, Type 4A, Axonal Form", "Charcot-Marie-Tooth Disease Type 2A2A", "Charcot-Marie-Tooth Disease Type 2S (Disorder)", "Charcot-Marie-Tooth Disease and Deafness", "Charcot-Marie-Tooth Disease Type 4B2", "Charcot-Marie-Tooth Disease Type 4H", "Charcot-Marie-Tooth Disease Type 1F", "Charcot-Marie-Tooth Disease Type 4C", "Charcot-Marie-Tooth Disease Type 4E", "Charcot-Marie-Tooth Disease Type 1D", "Charcot-Marie-Tooth Disease Type 2Q (Diagnosis)", "Charcot-Marie-Tooth Disease Type 2A2", "Charcot-Marie-Tooth Disease Type 2N (Diagnosis)", "Charcot-Marie-Tooth Disease Type 2B5", "Charcot-Marie-Tooth Disease Type 2D", "Charcot-Marie-Tooth Disease Type 4D", "Charcot-Marie-Tooth Disease Type 2K", "Charcot-Marie-Tooth Disease Type 2L (Diagnosis)", "Charcot-Marie-Tooth Disease Type 2T", "Charcot-Marie-Tooth Disease Type 2I", "Charcot-Marie-Tooth Disease Type 2J", "Charcot-Marie-Tooth Disease Type 2E", "Charcot-Marie-Tooth Disease Type 2G", "Charcot-Marie-Tooth Disease Type 1C", "Charcot-Marie-Tooth Disease Type 2R", "Charcot-Marie-Tooth Disease Type 2O (Diagnosis)", "Charcot-Marie-Tooth Disease Type 2M", "Charcot-Marie-Tooth Disease Type 2P", "Charcot-Marie-Tooth Disease Type 2Y", "Charcot-Marie-Tooth Disease Type 4F (Diagnosis)", "Charcot-Marie-Tooth Disease Type 4B3", "Charcot-Marie-Tooth Disease Type 2H", "HNPP", "X-Linked Charcot-Marie-Tooth Disease" ], "interventions": [], "intervention_types": [], "sponsor": "Hereditary Neuropathy Foundation", "sponsor_class": "OTHER_GOV", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": null, "sex": "ALL", "summary": "Not listed" }, "enrollment_count": 10000, "start_date": "2013-11-01", "completion_date": "2029-12-31", "has_results": false, "last_update_posted_date": "2024-10-01", "last_synced_at": "2026-06-11T09:28:29.492Z", "location_count": 1, "location_summary": "New York, New York", "locations": [ { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT05902351" }, { "nct_id": "NCT01676077", "title": "Clinical Outcome Study for Dysferlinopathy", "overall_status": "UNKNOWN", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Dysferlinopathy", "LGMD2B Now Classified as LGMDR2", "Miyoshi Myopathy" ], "interventions": [], "intervention_types": [], "sponsor": "Newcastle-upon-Tyne Hospitals NHS Trust", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "10 Years", "maximum_age": null, "sex": "ALL", "summary": "10 Years and older" }, "enrollment_count": 200, "start_date": "2012-09", "completion_date": "2024-03", "has_results": false, "last_update_posted_date": "2022-07-26", "last_synced_at": "2026-06-11T09:28:29.492Z", "location_count": 6, "location_summary": "Orange, California • Palo Alto, California • St Louis, Missouri + 3 more", "locations": [ { "city": "Orange", "state": "California" }, { "city": "Palo Alto", "state": "California" }, { "city": "St Louis", "state": "Missouri" }, { "city": "New York", "state": "New York" }, { "city": "Charlotte", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT01676077" }, { "nct_id": "NCT02841267", "title": "A Trial of PF-06252616 in Ambulatory Participants With LGMD2I", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "LGMD2I" ], "interventions": [ { "name": "PF 06252616", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Kathryn Wagner", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "99 Years", "sex": "ALL", "summary": "18 Years to 99 Years" }, "enrollment_count": 19, "start_date": "2016-07", "completion_date": "2019-01", "has_results": true, "last_update_posted_date": "2020-10-19", "last_synced_at": "2026-06-11T09:28:29.492Z", "location_count": 1, "location_summary": "Baltimore, Maryland", "locations": [ { "city": "Baltimore", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT02841267" } ] }